Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "265092",
"meta" : {
"versionId" : "4",
"lastUpdated" : "2024-11-16T19:44:32.460Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">[No data.]</div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Sheyu Li"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "Diabetes treatment medication [Database Entry: FHIR Group Resource]. Contributors: Sheyu Li [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 265092. Revised 2024-07-30. Available at: https://fevir.net/resources/Group/265092. Computable resource at: https://fevir.net/resources/Group/265092."
}
}
],
"url" : "https://fevir.net/resources/Group/265092",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "urn:ietf:rfc:3986",
"value" : "https://fevir.net/FOI/265092",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"title" : "Diabetes treatment medication",
"status" : "active",
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"description" : "SGLT-2 inhibitors, GLP-1 receptr agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones, sulfonylureas, metformin, α-glucosidase inhibitors, meglitinides, insulins, dual GIP/GLP-1 receptor agonists, or non-steroidal mineralocorticoid receptor antagonists",
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership" : "conceptual",
"combinationMethod" : "any-of",
"characteristic" : [
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "SGLT-2 inhibitor"
},
"exclude" : false,
"description" : "SGLT-2 inhibitors"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "GLP-1 receptr agonist"
},
"exclude" : false,
"description" : "GLP-1 receptr agonists"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "DPP-4 inhibitor"
},
"exclude" : false,
"description" : "DPP-4 inhibitors"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "thiazolidinedione"
},
"exclude" : false,
"description" : "thiazolidinediones"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "sulfonylurea"
},
"exclude" : false,
"description" : "sulfonylureas"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "metformin"
},
"exclude" : false,
"description" : "metformin"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "α-glucosidase inhibitor"
},
"exclude" : false,
"description" : "α-glucosidase inhibitors"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "meglitinide"
},
"exclude" : false,
"description" : "meglitinides"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "insulin"
},
"exclude" : false,
"description" : "insulins"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "dual GIP/GLP-1 receptor agonist"
},
"exclude" : false,
"description" : "dual GIP/GLP-1 receptor agonists"
},
{
"code" : {
"text" : "Drug class"
},
"valueCodeableConcept" : {
"text" : "non-steroidal mineralocorticoid receptor antagonist"
},
"exclude" : false,
"description" : "non-steroidal mineralocorticoid receptor antagonists"
}
]
}